# PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures

> **NCT07206329** · NA · COMPLETED · sponsor: **Unidade Local de Saúde do Alto Ave, EPE** · enrollment: 220 (actual)

## Conditions studied

- Bowel Preparation Solution

## Interventions

- **DRUG:** Polyethylene Glycol plus Ascorbic Acid (PEG-Asc)
- **DRUG:** Sodium Picosulfate with Magnesium Citrate (SPMC)

## Key facts

- **NCT ID:** NCT07206329
- **Lead sponsor:** Unidade Local de Saúde do Alto Ave, EPE
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07206329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07206329, "PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07206329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*